Monaco-based hormonal medicines supplier Besins Healthcare yesterday opened a new state-of-the-art hormone replacement therapy (HRT) production facility in Muel, near Zaragoza, Spain, to help meet the increased demand for HRT products for women across the UK, Europe, and the world.
The factory has opened within less than 18 months after ground was broken on the site in May 2022. Pending regulatory approvals, the facility should be able to provide new supplies by the middle of 2024 and future proofing the company’s increased supply of HRT medicines needed in the UK.
The UK demand for HRT medicines has increased significantly over the last two years and has led to some unforeseen shortages in supply and short-term supply interruptions.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze